Canopy Growth Corporation, Adaptive Biotechnologies Corporation, CRISPR Therapeutics AG and others have been slumping.
Leading equity indices in the US rose as S&P 500 gained 1.23% and closed at 4,450.38. Nasdaq ended the session at 13,800 after a 1.45% gain.
What is a downtrend?
The perceived tendency of a price to move in a downward direction over time. A downtrend describes the price movement of a continously depreciative financial asset over a particular time frame. In a downtrend, each successive low and peak is lower than the ones found earlier in the trend. The downtrend is therefore composed of lower swing lows and lower swing highs.
Canopy Growth continues a 14 day downtrend; dips 11.38% Friday
After setting a 38.4 cents – 43 cents range, Canopy Growth Corporation closed the day 11.38% lower at 38.79 cents. Early in Friday's session, Canopy Growth dropped to 38.4 cents from 43.77 cents at the end of Thursday, before closing at 38.79 cents. During the session, it lost 11.38%. Daily trading volume (29 million shares) increased, making up 212% of the 21-day average (13.69 million).
| Adaptive Biotechnologies | continues a 13 day decline; goes down 1.61% Friday
After setting a $6.7 – $7 range, Adaptive Biotechnologies closed the day 1.61% lower at $6.71. Grinding lower but with no clear-cut direction, the immune-driven medicine pioneer closed the session at $6.71 after forming a distinct $6.7 – $7 range. Friday's trading volume was 631,351 shares which is below the 21-day average of 1.11 million.
| CRISPR Therapeutics | continues a 27 day decline; stumbles 1.54% Friday
After setting a $55.83 – $58 range, CRISPR Therapeutics closed the day 1.54% lower at $56.14. After ending Thursday at $57.02, CRISPR Therapeutics dropped to $55.83 early in Friday's session and closed at $56.14. In total, it lost 1.54%. Trading volume totalled 1 million which equates to around 86% of the stock's 21-day average Friday.